Markets | | |
Share of JD.com (NASDAQ:JD) surged on March 2 after the company posted an increase in earnings and revenue. The company also posted an increase in annual active customer accounts of over 20% for the quarter. The stock was up over 9% in mid-day trading. This effectively made up for the stock’... Read the Full Story |
|
From Our PartnersThis little-known company is revolutionizing the way we identify cancer, and the its pipeline is filled with more cutting-edge medical advancements! Don't miss out on what could be a life-changing investment. | | Order your FREE report NOW! |
|
Markets | | | This Correction Isn't Over, Best To Be Prepared
The coronavirus has put the fear of God into the market. The indices are all down more than 10% over the last two weeks and well into “correction territory”. While it is true the selling began because of the virus, it is not exactly true t... Read the Full Story |
|
Markets | | |
If you're looking for a way to start a fight among brokers these days, one of the best ways may be to suggest that it's time to “buy the dip,” a term that means, essentially, start buying after a large-scale drop in stock prices. Some big names have come out against this concept, like ... Read the Full Story |
|
From Our PartnersDuring the 2017 crypto boom, Teeka’s top 5 recommendations (open and closed) could’ve turned every $500 into over $1 million. Now, in 2020, Teeka believes five tiny cryptos could make you as much as $5 million… starting with just $500 in each. It’s all thanks to a rare phenomenon that strikes the crypto market only once every four years. To prove it, Teeka’s flying YOU to the hidden epicenter of this phenomenon on Wednesday, March 18, at 8:00 pm ET, so you can see for yourself: the phenomenon is real. And it has true millionaire-making potential. When he lands, he’s officially releasing his new 5 coins to $5 million buy-list for 2020. Register for this historic online event while spots are still available. | | Click here to register for free |
|
Stocks | | | Scalping trades requires prudent decision-making and nimble reaction time. Both of these factors are enhanced through proper preparation ahead of the trade. The adage “Plan your trade and trade your plan.”, certainly rings true. We reviewed the tools and preparation routines in our Scalp... Read the Full Story |
|
Markets | | | Coming into the start of last month, Mylan (NASDAQ: MYL) shares were up about 30% since November and were starting to look like they wanted to put in a bottom. After dropping close to 80% from their lofty heights of 2015, you’d forgive investors for hoping and praying for just that. The $17 ma... Read the Full Story |
|
From Our PartnersInvesting in 5G is old news. I discovered a company with a revolutionary new technology that could be the next Cisco. I expect their $5 stock to climb to $90 and eventually as high as $1,200 per share. A $1,000 investment could grow to as much as $240,000. | | See this new tech - and get my #1 way to profit. |
|
The Early Bird Stock Of The Day West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. | | View Today's Stock Pick |
|
